Sign up for tax alert emails    GTNU homepage    Tax newsroom    Email document    Print document    Download document

January 24, 2019
2019-5106

Italy recognizes VAT reduced rate for medical devices used for therapeutic and prophylactic purposes

Executive summary

The Italian Budget Law 2019 (Law no.145/2018), published in the Official Gazette on 31 December 2018, clarifies that the reduced Value Added Tax (VAT) rate of 10% applicable for medicines also applies to medical devices based on substances generally used for therapeutic or prophylactic purposes and medical and veterinary treatments, classifiable in the tariff code 3004.

Medical devices not falling under the new provision could benefit from the reduced VAT rate should they be included in some other categories of products.

An analysis of the tariff codes of medical devices contained in the product portfolio can ensure the accurate application of the VAT rate and appropriate pricing.

Detailed discussion

Medical devices can be subject to the ordinary VAT rate of 22% or a reduced VAT rate of 10% or 4% respectively – provided that they are reported in one of the tables attached to DPR no. 633/1972.

The tables do not specifically mention medical devices, but rather Tariff codes. Consequently, in order to benefit from the reduced VAT rate, the devices have to be included in one of the categories reported under the appropriate nomenclature code.

VAT reduced rate on medical devices used for therapeutic or prophylactic purposes

Table A part III attached to DPR no. 633/1972, point 114, provides for the application of the reduced VAT rate of 10%, for medicines ready for human and veterinary use, including homeopathic products; pharmaceutical substances and medication items the provision of which is compulsory for pharmacies in accordance with the official pharmacopoeia.

The Budget Law for FY 2019 includes an authentic interpretation of point 114 of table A part III of DPR no. 633/1972, clarifying that medical devices used for therapeutic, prophylactic or preventive purposes and medical and veterinary treatments, classifiable in the code 3004 of the attachment 1, of Commission implementing regulation (EU) 2017/1925 of 12 October 2017, amending Annex 1 to Council Regulation(EEC) no. 2658/1987 on the tariff and statistical nomenclature and on the Common Customs Tariff, must be intended as included in point 114 of the table attached to DPR no. 633/1972 and therefore subject to the reduced 10% VAT rate.

In particular, nomenclature code 3004 includes medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale.

VAT reduced rate on medical devices not used for therapeutic or prophylactic purposes

Medical devices not falling under mentioned point 114 could however benefit from the reduced VAT rate provided that they are included in one of the other points of the tables attached to DPR no. 633/1972 such as:

  • Point 80 table A part III (10%): food preparations (combined nomenclature 21.06) not elsewhere specified or included elsewhere, except syrups.

and also

  • Point 30 of table A part II (4%): orthopedic instruments (including medical–surgical belts); devices and equipment for fractures (showers, slats and the like); devices and instruments for dentures, eyes and others; hearing aids and other hand-held equipment to be carried by persons or to be inserted in the entity, to compensate for a deficiency or a disability.
  • Point 33 of table A part II (4%): parts, spare parts and accessories intended exclusively for goods referred to in previous numbers 30).
  • Point 41-quarter of table A part II (4%): prostheses and aids related to functional permanent disability.

How to determine the correct VAT rate of medical devices

In order to ascertain the correct VAT rate of medical devices, taxpayers can file a request for technical analysis with the Italian Customs Authorities and then a ruling request with the Italian Revenue Agency.

For additional information with respect to this Alert, please contact the following:

Studio Legale Tributario, Rome
  • Nicoletta Mazzitelli | nicoletta.mazzitelli@it.ey.com
  • Valentina Casale | valentina.casale@it.ey.com
  • Emma Greco | emma.greco@it.ey.com
  • Serena Paone | serena.paone@it.ey.com
Studio Legale Tributario, Milan
  • Stefano Pavesi | stefano.pavesi@it.ey.com
  • Anselmo Martellotta | anselmo.martellotta@it.ey.com
  • Marco Cantisani | marco.cantisani@it.ey.com
  • Marion Dorré | marion.dorre@it.ey.com
  • Gabriella Cammarota, FSO | gabriella.cammarota@it.ey.com
Studio Legale Tributario, Treviso
  • Fabio Babolin | fabio.babolin@it.ey.com
Studio Legale Tributario, Turin
  • Anna Paola Deiana | anna-paola.deiana@it.ey.com

ATTACHMENT

 
 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 2024, Ernst & Young LLP.

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

Any U.S. tax advice contained herein was not intended or written to be used, and cannot be used, by the recipient for the purpose of avoiding penalties that may be imposed under the Internal Revenue Code or applicable state or local tax law provisions.

 

"EY" refers to the global organisation, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.

 

Privacy  |  Cookies  |  BCR  |  Legal  |  Global Code of Conduct Opt out of all email from EY Global Limited.

 


Cookie Settings

This site uses cookies to provide you with a personalized browsing experience and allows us to understand more about you. More information on the cookies we use can be found here. By clicking 'Yes, I accept' you agree and consent to our use of cookies. More information on what these cookies are and how we use them, including how you can manage them, is outlined in our Privacy Notice. Please note that your decision to decline the use of cookies is limited to this site only, and not in relation to other EY sites or ey.com. Please refer to the privacy notice/policy on these sites for more information.


Yes, I accept         Find out more